{"id":"https://openalex.org/W4224253333","doi":"https://doi.org/10.3390/pharmaceutics14040823","title":"Cell-Penetrating Peptides with Unexpected Anti-Amyloid Properties","display_name":"Cell-Penetrating Peptides with Unexpected Anti-Amyloid Properties","alternate_titles":[],"publication_year":2022,"publication_date":"2022-04-09","ids":{"openalex":"https://openalex.org/W4224253333","doi":"https://doi.org/10.3390/pharmaceutics14040823","pmid":"https://pubmed.ncbi.nlm.nih.gov/35456657","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9027922"},"language":"en","primary_location":{"id":"doi:10.3390/pharmaceutics14040823","doi":"https://doi.org/10.3390/pharmaceutics14040823","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics14040823","pdf_url":"https://www.mdpi.com/1999-4923/14/4/823/pdf?version=1649468930","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4224253333"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/1999-4923/14/4/823/pdf?version=1649468930","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063014705","display_name":"Nicklas \u00d6sterlund","orcid":"https://orcid.org/0000-0003-0905-7911","observed_orcids":["https://orcid.org/0000-0003-0905-7911"]},"institutions":[{"id":"https://openalex.org/I161593684","display_name":"Stockholm University","ror":"https://ror.org/05f0yaq80","country_code":"SE","type":"education","lineage":["https://openalex.org/I161593684"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Nicklas \u00d6sterlund","raw_affiliation_strings":["Department of Biochemistry and Biophysics, Arrhenius Laboratories, Stockholm University, 10691 Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Biophysics, Arrhenius Laboratories, Stockholm University, 10691 Stockholm, Sweden","institution_ids":["https://openalex.org/I161593684"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048514475","display_name":"Sebastian K.T.S. W\u00e4rml\u00e4nder","orcid":"https://orcid.org/0000-0003-3917-1838","observed_orcids":["https://orcid.org/0000-0003-3917-1838","https://orcid.org/0000-0001-6836-5610"]},"institutions":[{"id":"https://openalex.org/I161593684","display_name":"Stockholm University","ror":"https://ror.org/05f0yaq80","country_code":"SE","type":"education","lineage":["https://openalex.org/I161593684"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Sebastian K. T. S. W\u00e4rml\u00e4nder","raw_affiliation_strings":["CellPept Sweden AB, Kvarngatan 10B, 11847 Stockholm, Sweden","Department of Archaeology and Classical Studies, Stockholm University, 10691 Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CellPept Sweden AB, Kvarngatan 10B, 11847 Stockholm, Sweden","institution_ids":[]},{"raw_affiliation_string":"Department of Archaeology and Classical Studies, Stockholm University, 10691 Stockholm, Sweden","institution_ids":["https://openalex.org/I161593684"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034635485","display_name":"Astrid Gr\u00e4slund","orcid":"https://orcid.org/0000-0003-2187-1537","observed_orcids":["https://orcid.org/0000-0003-2187-1537","https://orcid.org/0009-0008-0486-5032"]},"institutions":[{"id":"https://openalex.org/I161593684","display_name":"Stockholm University","ror":"https://ror.org/05f0yaq80","country_code":"SE","type":"education","lineage":["https://openalex.org/I161593684"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Astrid Gr\u00e4slund","raw_affiliation_strings":["CellPept Sweden AB, Kvarngatan 10B, 11847 Stockholm, Sweden","Department of Biochemistry and Biophysics, Arrhenius Laboratories, Stockholm University, 10691 Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CellPept Sweden AB, Kvarngatan 10B, 11847 Stockholm, Sweden","institution_ids":[]},{"raw_affiliation_string":"Department of Biochemistry and Biophysics, Arrhenius Laboratories, Stockholm University, 10691 Stockholm, Sweden","institution_ids":["https://openalex.org/I161593684"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5034635485"],"corresponding_institution_ids":["https://openalex.org/I161593684"],"apc_list":{"value":2400,"currency":"CHF","value_usd":2513},"apc_paid":{"value":2064,"currency":"EUR","value_usd":2226},"fwci":0.2992,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.26014503,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"14","issue":"4","first_page":"823","last_page":"823"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11335","display_name":"Prion Diseases and Protein Misfolding","score":0.7554000020027161,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11335","display_name":"Prion Diseases and Protein Misfolding","score":0.7554000020027161,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.22779999673366547,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cell-penetrating-peptides","display_name":"cell-penetrating peptides","score":1.0},{"id":"https://openalex.org/keywords/prion-protein","display_name":"prion protein","score":0.9380000233650208},{"id":"https://openalex.org/keywords/anti-amyloid-activity","display_name":"anti-amyloid activity","score":0.8759999871253967},{"id":"https://openalex.org/keywords/amyloid-beta","display_name":"amyloid-beta","score":0.8970000147819519},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9589999914169312},{"id":"https://openalex.org/keywords/hexapeptide","display_name":"hexapeptide","score":0.7059999704360962},{"id":"https://openalex.org/keywords/peptide-aggregation","display_name":"peptide aggregation","score":0.6740000247955322},{"id":"https://openalex.org/keywords/coaggregation","display_name":"co-aggregation","score":0.8539999723434448}],"concepts":[{"id":"https://openalex.org/C2777633098","wikidata":"https://www.wikidata.org/wiki/Q2736051","display_name":"Amyloid (mycology)","level":2,"score":0.701431155204773},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.6824852824211121},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6448336243629456},{"id":"https://openalex.org/C3019804061","wikidata":"https://www.wikidata.org/wiki/Q14881255","display_name":"Prion protein","level":3,"score":0.6418653130531311},{"id":"https://openalex.org/C2778112365","wikidata":"https://www.wikidata.org/wiki/Q3511065","display_name":"Sequence (biology)","level":2,"score":0.6411536335945129},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.6319962739944458},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5434617400169373},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.5253053307533264},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.49628669023513794},{"id":"https://openalex.org/C167625842","wikidata":"https://www.wikidata.org/wiki/Q899763","display_name":"Peptide sequence","level":3,"score":0.4857385754585266},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4627962112426758},{"id":"https://openalex.org/C10858879","wikidata":"https://www.wikidata.org/wiki/Q899790","display_name":"Signal peptide","level":4,"score":0.4462778866291046},{"id":"https://openalex.org/C2776929087","wikidata":"https://www.wikidata.org/wiki/Q189096","display_name":"Cell-penetrating peptide","level":3,"score":0.4421796500682831},{"id":"https://openalex.org/C136238340","wikidata":"https://www.wikidata.org/wiki/Q7251455","display_name":"Protein aggregation","level":2,"score":0.4310770630836487},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.42963361740112305},{"id":"https://openalex.org/C2909607560","wikidata":"https://www.wikidata.org/wiki/Q6740853","display_name":"Amyloid disease","level":5,"score":0.426326721906662},{"id":"https://openalex.org/C3019447875","wikidata":"https://www.wikidata.org/wiki/Q417667","display_name":"Amyloid \u03b2","level":3,"score":0.40118643641471863},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23597371578216553},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.16234150528907776},{"id":"https://openalex.org/C2994168385","wikidata":"https://www.wikidata.org/wiki/Q6740853","display_name":"Amyloid fibril","level":4,"score":0.14096930623054504},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09374067187309265},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0785285234451294},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07597097754478455},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C179104552","wikidata":"https://www.wikidata.org/wiki/Q11165","display_name":"Inorganic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3390/pharmaceutics14040823","doi":"https://doi.org/10.3390/pharmaceutics14040823","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics14040823","pdf_url":"https://www.mdpi.com/1999-4923/14/4/823/pdf?version=1649468930","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:35456657","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35456657","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9027922","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9027922/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:318c315cec964bffa63e4b4aea88afcd","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/318c315cec964bffa63e4b4aea88afcd","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmaceutics, Vol 14, Iss 4, p 823 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3390/pharmaceutics14040823","doi":"https://doi.org/10.3390/pharmaceutics14040823","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics14040823","pdf_url":"https://www.mdpi.com/1999-4923/14/4/823/pdf?version=1649468930","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322581","display_name":"Vetenskapsr\u00e5det","ror":"https://ror.org/03zttf063"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4224253333.pdf","grobid_xml":"https://content.openalex.org/works/W4224253333.grobid-xml"},"referenced_works_count":46,"referenced_works":["https://openalex.org/W1966588993","https://openalex.org/W1978314140","https://openalex.org/W1984192248","https://openalex.org/W1996362083","https://openalex.org/W2008624037","https://openalex.org/W2027793140","https://openalex.org/W2038119237","https://openalex.org/W2060914703","https://openalex.org/W2067106749","https://openalex.org/W2103865712","https://openalex.org/W2127582578","https://openalex.org/W2137501083","https://openalex.org/W2140059341","https://openalex.org/W2144535585","https://openalex.org/W2160770834","https://openalex.org/W2171091522","https://openalex.org/W2225657959","https://openalex.org/W2329336071","https://openalex.org/W2555151293","https://openalex.org/W2769257790","https://openalex.org/W2774913139","https://openalex.org/W2789317478","https://openalex.org/W2800412985","https://openalex.org/W2900871657","https://openalex.org/W2912990441","https://openalex.org/W2918676206","https://openalex.org/W2946968312","https://openalex.org/W2948234529","https://openalex.org/W2973160898","https://openalex.org/W2984016928","https://openalex.org/W3002004946","https://openalex.org/W3011219180","https://openalex.org/W3015856745","https://openalex.org/W3022508929","https://openalex.org/W3028072960","https://openalex.org/W3034762187","https://openalex.org/W3047154508","https://openalex.org/W3048901815","https://openalex.org/W3086215371","https://openalex.org/W3094137032","https://openalex.org/W3112255842","https://openalex.org/W3178404698","https://openalex.org/W3182516620","https://openalex.org/W4211102684","https://openalex.org/W4231218346","https://openalex.org/W6788490184"],"related_works":["https://openalex.org/W3002004946","https://openalex.org/W2584464034","https://openalex.org/W4319871770","https://openalex.org/W3021466134","https://openalex.org/W7148358068","https://openalex.org/W4404280412","https://openalex.org/W2140059341","https://openalex.org/W4321497330","https://openalex.org/W2548384558","https://openalex.org/W2289962851"],"abstract_inverted_index":{"Cell-penetrating":[0],"peptides":[1,98],"(CPPs)":[2],"with":[3],"sequences":[4,50],"derived":[5],"originally":[6],"from":[7],"a":[8,54,60],"prion":[9,24,72],"protein":[10,73,84],"(PrP)":[11],"have":[12],"been":[13],"shown":[14],"to":[15,77,132,140],"exhibit":[16],"both":[17],"anti-prion":[18,88],"and":[19,26,45,110,116],"anti-amyloid":[20],"properties":[21,37],"particularly":[22],"against":[23],"proteins":[25],"the":[27,71,78,82,87,91,114,134,151],"amyloid-\u03b2":[28],"(A\u03b2)":[29],"peptide":[30],"active":[31],"in":[32,42,46,121,157],"Alzheimer's":[33],"disease.":[34],"These":[35,127],"disease-modifying":[36],"are":[38,51,99],"so":[39],"far":[40],"observed":[41,120],"cell":[43],"cultures":[44],"vitro.":[47],"The":[48,66],"CPP":[49,97],"composed":[52],"of":[53,70,81,95],"hydrophobic":[55],"signal":[56,68,79],"sequence":[57,69,80],"followed":[58],"by":[59,108],"highly":[61],"positively":[62],"charged":[63],"hexapeptide":[64],"segment.":[65],"original":[67],"can":[74,118],"be":[75,119],"changed":[76],"NCAM1":[83],"without":[85],"losing":[86],"activity.":[89],"Although":[90],"detailed":[92],"molecular":[93,111,143],"mechanisms":[94],"these":[96],"not":[100],"fully":[101],"understood,":[102],"they":[103],"do":[104],"form":[105],"amyloid":[106],"aggregates":[107],"themselves,":[109],"interactions":[112,130],"between":[113],"CPPs":[115],"PrP/A\u03b2":[117,153],"vitro":[122],"using":[123],"various":[124],"spectroscopic":[125],"techniques.":[126],"initial":[128],"intermolecular":[129],"appear":[131],"re-direct":[133],"aggregation":[135,154],"pathways":[136],"for":[137],"prion/amyloid":[138],"formation":[139],"less":[141],"cell-toxic":[142],"structures":[144],"(i.e.,":[145],"co-aggregates),":[146],"which":[147],"likely":[148],"is":[149,155],"why":[150],"disease-inducing":[152],"counteracted":[156],"vivo.":[158]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4224253333","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-04-26T00:00:00"}
